Cobalt Pharmaceuticals receives Notice of Compliance from Health Canada to market Atorvastatin Calcium Tablets Watson Pharmaceuticals, Inc. today announced that its subsidiary Cobalt Pharmaceuticals has received a Notice of Compliance from Wellness Canada to market Atorvastatin Calcium Tablets in the 10, 20, 40 and 80 mg strengths. ‘We are very pleased that our Cobalt company will become adding this important therapy to its expanding portfolio of items,’ said Paul Bisaro, CEO and President of Watson Pharmaceuticals, Inc.’.Further useful properties could be included in the fluorescent proteins by genetic engineering. Moreover , they state, the discovery of photoswitchable cerFP505 from a deep sea pet reveals the lightless depths of the oceans as a fresh reservoir of proteins with novel and extremely attractive properties for imaging applications .

Aromatherapy might have elevated degrees of harmful indoor atmosphere pollutants Spas that offer massage therapy using fragrant essential oils, called aromatherapy, might have elevated levels of potentially harmful indoor air pollutants such as for example volatile organic compounds and ultrafine particles, according to an article in Environmental Engineering Science, a peer-reviewed journal published by Mary Ann Liebert, Inc.